Orosomucoid 1 Participates in Alveolar Hypercoagulation and Fibrinolytic Inhibition Involving NF ‐ κB Signaling Pathway in LPS ‐Induced ARDS
The FASEB Journal · 2025
DOI: 10.1096/fj.202502459rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Xianjun Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Unit, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China. Hauptthemen laut MEDLINE: Respiratory Distress Syndrome, NF-kappa B, Lipopolysaccharides, Signal Transduction. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Guizhou Provincial Health and Wellness Commission Science and Technology Fund Project, The Cultivate project 2024 for National Natural Science Foundation of China, the Affiliated Hospital of Guizhou Medical University, Guizhou Medical University Affiliated Hospital Doctoral Initiation Grant Program.
Abstract (Originalsprache)
Alveolar hypercoagulation and fibrinolytic inhibition are key drivers of refractory hypoxemia in acute respiratory distress syndrome (ARDS). Orosomucoid 1 (ORM1), associated with coagulation and the NF‐κB pathway, is hypothesized to regulate these processes in ARDS via NF‐κB. By using LPS‐induced ARDS rats and alveolar epithelial type II (AEC II) cells, we measured ORM1 expression and its effects on tissue factor (TF) and plasminogen activator inhibitor‐1 (PAI‐1). NF‐κB pathway involvement was assessed. Clinically, bronchoalveolar lavage fluid (BALF) ORM1 levels and their correlation with TF/PAI‐1 were analyzed in ARDS patients. In ARDS rats, ORM1 was upregulated in lung tissue and BALF, correlating with increased TF, PAI‐1, and type III collagen. In vitro, ORM1 promoted TF and PAI‐1 expression in LPS‐stimulated AEC II cells. These effects were mediated through the NF‐κB pathway. Clinically, BALF ORM1 levels were elevated in ARDS patients and positively correlated with TF and PAI‐1. ORM1 regulates alveolar hypercoagulation and fibrinolytic inhibition in LPS‐induced ARDS via the NF‐κB pathway, identifying it as a promising therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Intensive Care Unit, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
- Department of Respiratory and Critical Care Medicine, Wuhan No. 1 Hospital, Wuhan, Hubei, China.
- Department of Anorectal Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
- Department of Clinical Medicine, Xi'an Medical College, Xi'an, Shaanxi, China.
ORCID-Profile: Xianjun Chen, Feng Shen
Förderung
- The Guizhou Provincial Health and Wellness Commission Science and Technology Fund Project
- The Cultivate project 2024 for National Natural Science Foundation of China, the Affiliated Hospital of Guizhou Medical University
- Guizhou Medical University Affiliated Hospital Doctoral Initiation Grant Program
- National Natural Science Foundation of China
- 2021 In-Hospital Clinical Research Project of the Affiliated Hospital of Guizhou Medical University
Zitieren
APA
Chen, X., Liu, Y., Mu, S., Chen, T., Yuan, J., Xiao, C., Dong, Q., Li, Q., Wang, Y., Chen, Q., Li, S., Li, W., & Shen, F. (2025). Orosomucoid 1 Participates in Alveolar Hypercoagulation and Fibrinolytic Inhibition Involving NF ‐ κB Signaling Pathway in LPS ‐Induced ARDS. The FASEB Journal. https://doi.org/10.1096/fj.202502459rr
Vancouver
Chen X, Liu Y, Mu S, Chen T, Yuan J, Xiao C, et al. Orosomucoid 1 Participates in Alveolar Hypercoagulation and Fibrinolytic Inhibition Involving NF ‐ κB Signaling Pathway in LPS ‐Induced ARDS. The FASEB Journal. 2025. doi:10.1096/fj.202502459rr
BibTeX
@article{Chen2025,
author = {Chen, Xianjun and Liu, Ying and Mu, Song and Chen, Tingting and Yuan, Jia and Xiao, Chuan and Dong, Qi and Li, Qing and Wang, Ying and Chen, Qimin and Li, Shuwen and Li, Wei and Shen, Feng},
title = {Orosomucoid 1 Participates in Alveolar Hypercoagulation and Fibrinolytic Inhibition Involving NF ‐ κB Signaling Pathway in LPS ‐Induced ARDS},
journal = {The FASEB Journal},
year = {2025},
doi = {10.1096/fj.202502459rr}
}
EUVIMED